Wakamoto Pharmaceutical
4512.T
#10175
Rank
A$91.32 M
Marketcap
A$2.63
Share price
-0.35%
Change (1 day)
-6.03%
Change (1 year)

Revenue for Wakamoto Pharmaceutical (4512.T)

Revenue in 2026 (TTM): A$97.7 Million

According to Wakamoto Pharmaceutical's latest financial reports the company's current revenue (TTM ) is A$95.04 Million. In 2025 the company made a revenue of A$96.41 Million a decrease over the revenue in the year 2024 that were of A$0.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Wakamoto Pharmaceutical from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) A$97.7 M1.34%
2025 A$96.41 M-21.42%
2024 A$0.12 B47.84%
2023 A$82.99 M-10.71%
2022 A$92.95 M-10.96%
2021 A$0.10 B-6.61%
2020 A$0.11 B-23.41%
2019 A$0.14 B6.91%
2018 A$0.13 B9.92%
2017 A$0.12 B-11.68%
2016 A$0.14 B10.74%
2015 A$0.12 B6.31%
2014 A$0.11 B1.52%
2013 A$0.11 B4.6%
2012 A$0.11 B-5.41%
2011 A$0.11 B9.87%
2010 A$0.10 B-6.92%
2009 A$0.11 B